
Approximately 25% of patients with schizophrenia remain actively psychotic despite treatment with conventional antipsychotic medication. Many of these patients become new long-stay patients or are frequent readmissions to psychiatric hospitals. This article reviews some of the causes of treatment resistance and the management of this group of patients.
Drug Combinations, Chemotherapy, Adjuvant, Drug Resistance, Schizophrenia, Humans, Antipsychotic Agents
Drug Combinations, Chemotherapy, Adjuvant, Drug Resistance, Schizophrenia, Humans, Antipsychotic Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
